0001179110-21-009904.txt : 20211105
0001179110-21-009904.hdr.sgml : 20211105
20211105163127
ACCESSION NUMBER: 0001179110-21-009904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211103
FILED AS OF DATE: 20211105
DATE AS OF CHANGE: 20211105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenfield Andrew J
CENTRAL INDEX KEY: 0001372715
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09585
FILM NUMBER: 211385063
BUSINESS ADDRESS:
BUSINESS PHONE: 978-352-3815
MAIL ADDRESS:
STREET 1: 14 HILLSIDE DRIVE
CITY: GEORGETOWN
STATE: MA
ZIP: 01833
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABIOMED INC
CENTRAL INDEX KEY: 0000815094
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042743260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 22 CHERRY HILL DR
CITY: DANVERS
STATE: MA
ZIP: 01923
BUSINESS PHONE: 9787775410
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DRIVE
CITY: DANVERS
STATE: MA
ZIP: 01923
4
1
edgar.xml
FORM 4 -
X0306
4
2021-11-03
0
0000815094
ABIOMED INC
ABMD
0001372715
Greenfield Andrew J
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE
DANVERS
MA
01923
0
1
0
0
VP, Chief Commercial Officer
Common Stock, $.01 par value
2021-11-03
4
A
0
6975
0
A
44769
D
Common Stock, $.01 par value
2021-11-03
4
F
0
1549
349.76
D
43220
D
Common Stock, $.01 par value
12032
I
By Trust
Stock Option (right to buy)
99.62
2017-05-24
2026-05-24
Common Stock
0
5000
D
Stock Option (right to buy)
134.51
2018-05-15
2027-05-15
Common Stock
0
6500
D
Stock Option (right to buy)
381.97
2019-05-16
2028-05-16
Common Stock
0
4000
D
Stock Option (right to buy)
266.39
2020-05-30
2029-05-30
Common Stock
0
7000
D
Stock Option (right to buy
223.9
2021-05-29
2030-05-29
Common Stock
0
4896
D
Stock Option (right to buy)
283.88
2022-05-25
2031-05-25
Common Stock
0
2868
D
These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates.
Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
/s/ Marc A. Began (by power of attorney)
2021-11-05
EX-24
2
ex24greenfield.txt
LIMITED POWER OF ATTORNEY
The undersigned does hereby appoint each of
Todd A. Trapp, Marc A. Began and Michael Dube, signing
singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the
undersigned, in the undersigned's capacity as a
director or officer of ABIOMED, Inc. (the "Company"),
Forms 3, 4 and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934 and the rules
thereunder;
(2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or
desirable to complete and execute any such Form 3, 4
or 5 and timely file such form with the United States
Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever
in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the
undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall
be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-
fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are
not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this power of attorney has
been executed as of the 30th day of June, 2021 and
shall remain in full force and effect until withdrawn
by the undersigned in writing.
Signature: /s/ Andrew J. Greenfield
Print Name: Andrew J. Greenfield